Main Content

Empire Life launches digital enrolment: automated plan member enrolment saves time and delivers a more streamlined experience

On May 5, 2023, Empire Life released its digital enrolment tool to plan administrators across Canada. The new tool automates the collection of enrolment information from plan administrators and plan members in one seamless and time saving process. Our small group of customers with modular flex benefits will receive access to digital enrolment in our next release.  

The new digital enrolment tool eliminates almost all of the administration work and makes enrolment simple, fast and easy every step of the way: 

News - Site Select

Empire Life reports excellent customer service with Trident Global Assistance in first year of new relationship

Celebrating first year anniversary with new service provider, May 1, 2023

Air passenger traffic regained momentum in 2022, according to IATA, as travel restrictions were removed and passengers showed strong interest in travel. Passenger traffic grew from 42 per cent of pre-pandemic (2019) volumes in 2021 to 69 per cent in 2022.

News - Site Select

Group insurance fraud costs group plan sponsors $400 million a year or more

Empire Life and CLHIA highlight fraud prevention in group insurance market

Stephen Frank, President and CEO of the CLHIA, says fraudsters are mounting more sophisticated schemes, and that the industry has adjusted, as a result. “We’re putting more resources into fraud prevention and detection, we’re investing more in technology, and generally spending more energy on combating fraud collectively across the industry. Empire Life has been a huge partner in that, and really a driving force on helping us get to where we are,” said Frank.

News - Site Select

Spotlight on biosimilars

Action required for plan members in Saskatchewan and Ontario who take a biologic drug

Ontario and Saskatchewan are the latest provinces to adopt biosimilar initiatives. Biologic drugs generally cost over $10,000 per patient per year. Biosimilars can be created once the patent for the biologic expires, and they cost much less. Biosimilar initiatives aim to transition patients from biologics to biosimilars wherever possible.

News - Site Select

Empire Life reports strong fourth quarter earnings for 2022

Q4 2022 highlights (compared to Q4 2021)

  • Common shareholders’ net income of $87 million (compared to $17 million)
  • Earnings per share (basic and diluted) of $88.93 (compared to $16.96)

 

Full year 2022 highlights (compared to full year 2021)

  • Common shareholders’ net income of $204 million (compared to $239 million)
  • Earnings per share (basic and diluted) of $207.32 (compared to $242.66)

 

News - Site Select